Braftovi (encorafenib)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Braftovi (encorafenib), covering 2025-08-01 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer [Phase 2]